Mitchell Levine

6.9k total citations · 1 hit paper
161 papers, 4.2k citations indexed

About

Mitchell Levine is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mitchell Levine has authored 161 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Economics and Econometrics, 34 papers in General Health Professions and 25 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mitchell Levine's work include Health Systems, Economic Evaluations, Quality of Life (38 papers), Pharmaceutical Practices and Patient Outcomes (18 papers) and Pharmaceutical Economics and Policy (13 papers). Mitchell Levine is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (38 papers), Pharmaceutical Practices and Patient Outcomes (18 papers) and Pharmaceutical Economics and Policy (13 papers). Mitchell Levine collaborates with scholars based in Canada, United States and China. Mitchell Levine's co-authors include Lehana Thabane, Guowei Li, Pasqualina Santaguida, Parminder Raina, Lynda Booker, David Cowan, Mark Oremus, Christopher Patterson, Afisi Ismaila and Jonathan D. Adachi and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mitchell Levine

147 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

2008 560 citations Mitchell Levine et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell Levine Canada	33	549	528	525	477	438	161	4.2k
Rebecca A. Hubbard United States	38	486 0.9×	530 1.0×	441 0.8×	449 0.9×	672 1.5×	237	5.7k
Francesco Lapi Italy	33	507 0.9×	556 1.1×	218 0.4×	273 0.6×	192 0.4×	163	4.2k
Richard A. Hansen United States	39	423 0.8×	443 0.8×	510 1.0×	751 1.6×	1.2k 2.7×	216	6.3k
Paola Baiardi Italy	36	724 1.3×	513 1.0×	363 0.7×	237 0.5×	376 0.9×	141	4.5k
Christopher J. Weir United Kingdom	48	746 1.4×	550 1.0×	370 0.7×	457 1.0×	471 1.1×	220	8.0k
Michele Freeman United States	35	1.3k 2.4×	323 0.6×	1.2k 2.3×	675 1.4×	347 0.8×	94	6.2k
Klaas H. Groenier Netherlands	43	661 1.2×	456 0.9×	585 1.1×	245 0.5×	285 0.7×	165	5.5k
Catherine M. Viscoli United States	32	744 1.4×	356 0.7×	289 0.6×	308 0.6×	218 0.5×	76	4.7k
Kathleen A. Lane United States	40	660 1.2×	532 1.0×	377 0.7×	156 0.3×	1000 2.3×	124	4.4k
Antonella Zambon Italy	39	1.6k 2.9×	801 1.5×	363 0.7×	398 0.8×	242 0.6×	194	6.5k

Countries citing papers authored by Mitchell Levine

Since Specialization

Citations

This map shows the geographic impact of Mitchell Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Levine more than expected).

Fields of papers citing papers by Mitchell Levine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Levine. The network helps show where Mitchell Levine may publish in the future.

Co-authorship network of co-authors of Mitchell Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Levine. A scholar is included among the top collaborators of Mitchell Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Levine. Mitchell Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tao, Liyuan, et al.. (2025). Inadequate Reporting of Harm From Randomized Clinical Trials in Top Medical Publications. Journal of Evidence-Based Medicine. 18(1). e70006–e70006. 1 indexed citations

Busse, Jason W., Behnam Sadeghirad, Mitchell Levine, et al.. (2025). Cost-Effectiveness of Medical Cannabis Versus Opioids for Chronic Noncancer Pain. Cannabis and Cannabinoid Research. 10(3). 467–479. 1 indexed citations

Astaneh, Behrooz, et al.. (2024). Pedagogic Strategies and Contents in Medical Writing/Publishing Education: A Comprehensive Systematic Survey. European Journal of Investigation in Health Psychology and Education. 14(9). 2491–2508.

Sheats, Rose D., Mitchell Levine, Ghizlane Aarab, et al.. (2024). Novel Therapies for Preventing, Managing and Treating Obstructive Sleep Apnea and Snoring in Pediatric and Adult Patients. 11(2). 6 indexed citations

Busse, Jason W., Behnam Sadeghirad, Mitchell Levine, et al.. (2024). Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials. BMJ Open. 14(1). e068182–e068182. 9 indexed citations

Levine, Mitchell, et al.. (2023). Health Technology Reassessment: Addressing Uncertainty in Economic Evaluations of Oncology Drugs at Time of Reimbursement Using Long-Term Clinical Trial Data. Current Oncology. 30(7). 6596–6608. 1 indexed citations

Levine, Mitchell, et al.. (2023). A Massive Acetaminophen Overdose with Unusual Pharmacokinetics. 18(1). 9–13. 1 indexed citations

Holbrook, Anne, Michael Rieder, Michelle Gibson, et al.. (2019). Prescribing competency assessment for Canadian medical students: a pilot evaluation. SHILAP Revista de lepidopterología. 10(1). e103–110. 10 indexed citations

Dolovich, Lisa & Mitchell Levine. (2018). The Development and Implementation of a Medication Assessment Clinic. The Canadian Journal of Hospital Pharmacy. 50(4).

10.

Li, Guowei, Gregory Y.H. Lip, Anne Holbrook, et al.. (2018). Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. European Journal of Epidemiology. 34(2). 173–190. 55 indexed citations

11.

Tsoi, Bernice, Leo E. Akioyamen, Ashley Bonner, et al.. (2017). Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart Lung and Circulation. 27(6). 666–682. 15 indexed citations

12.

Li, Guowei, Lawrence Mbuagbaw, Zainab Samaan, et al.. (2017). State of reporting of primary biomedical research: a scoping review protocol. BMJ Open. 7(3). e014749–e014749. 3 indexed citations

13.

Li, Guowei, Mitchell Levine, Gordon Guyatt, et al.. (2015). Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients. Medicine. 94(36). e1479–e1479. 23 indexed citations

14.

Levine, Mitchell, et al.. (2014). Patient-specific academic detailing for smoking cessation: feasibility study.. PubMed. 60(1). e16–23. 7 indexed citations

15.

Rodger, Ian W., Janet Dwyer, John Bienenstock, et al.. (2013). Evidence against the Involvement of Chronic Cerebrospinal Venous Abnormalities in Multiple Sclerosis. A Case-Control Study. PLoS ONE. 8(8). e72495–e72495. 18 indexed citations

16.

Levine, Mitchell, et al.. (2008). Medical residents' and students' attitudes towards herbal medicines: a pilot study.. PubMed. 15(1). e1–4. 31 indexed citations

17.

McCormack, James, Lisa Dolovich, Mitchell Levine, et al.. (2003). Providing evidence‐based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?. Health Expectations. 6(4). 281–289. 16 indexed citations

18.

Zarnke, Kelly B., Mitchell Levine, & Bernie J. OʼBrien. (1997). Cost-Benefit Analyses in the Health-Care Literature: Don't Judge a Study by Its Label. Journal of Clinical Epidemiology. 50(7). 813–822. 63 indexed citations

19.

Walker, Valery, et al.. (1995). Health-Related Quality of Life in Patients With Major Depression Who Are Treated With Moclobemide. Journal of Clinical Psychopharmacology. 15(4 Suppl 2). 60S–67S. 18 indexed citations

20.

Levine, Mitchell. (1992). A Guide for Assessing Pharmacoepidemiologic Studies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 12(3). 232–237. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact